IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,811,372 | -9.3% | 1,641,887 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $17,434,905 | +1.1% | 1,638,619 | +0.0% | 0.00% | 0.0% |
Q1 2023 | $17,237,494 | -14.7% | 1,638,545 | +0.5% | 0.00% | -25.0% |
Q4 2022 | $20,202,874 | +24.8% | 1,630,579 | +4.4% | 0.00% | 0.0% |
Q3 2022 | $16,183,000 | -14.4% | 1,562,093 | -4.7% | 0.00% | 0.0% |
Q2 2022 | $18,896,000 | -7.4% | 1,638,893 | +1.1% | 0.00% | 0.0% |
Q1 2022 | $20,397,000 | +3.9% | 1,621,340 | -3.7% | 0.00% | +33.3% |
Q4 2021 | $19,628,000 | -13.1% | 1,683,370 | -2.6% | 0.00% | -25.0% |
Q3 2021 | $22,579,000 | +1.4% | 1,728,883 | -0.1% | 0.00% | 0.0% |
Q2 2021 | $22,271,000 | +7.4% | 1,730,416 | -6.7% | 0.00% | 0.0% |
Q1 2021 | $20,735,000 | -7.9% | 1,854,700 | -6.2% | 0.00% | 0.0% |
Q4 2020 | $22,512,000 | +22.8% | 1,976,431 | -3.0% | 0.00% | 0.0% |
Q3 2020 | $18,335,000 | -17.9% | 2,038,249 | -5.8% | 0.00% | -20.0% |
Q2 2020 | $22,321,000 | +8.0% | 2,162,983 | +5.6% | 0.01% | -16.7% |
Q1 2020 | $20,660,000 | -22.4% | 2,047,538 | +2.3% | 0.01% | 0.0% |
Q4 2019 | $26,628,000 | +58.5% | 2,000,626 | +2.2% | 0.01% | +50.0% |
Q3 2019 | $16,804,000 | -14.1% | 1,957,355 | +9.5% | 0.00% | -20.0% |
Q2 2019 | $19,555,000 | -17.6% | 1,787,453 | +1.9% | 0.01% | -16.7% |
Q1 2019 | $23,732,000 | +33.8% | 1,753,995 | +2.4% | 0.01% | +20.0% |
Q4 2018 | $17,738,000 | -42.8% | 1,712,129 | +2.0% | 0.01% | -37.5% |
Q3 2018 | $30,997,000 | -1.3% | 1,679,122 | +2.3% | 0.01% | 0.0% |
Q2 2018 | $31,392,000 | +30.3% | 1,641,866 | +5.1% | 0.01% | +33.3% |
Q1 2018 | $24,099,000 | +3.2% | 1,561,766 | +0.3% | 0.01% | 0.0% |
Q4 2017 | $23,342,000 | -7.6% | 1,557,153 | -2.8% | 0.01% | -14.3% |
Q3 2017 | $25,265,000 | -17.6% | 1,602,082 | -1.4% | 0.01% | -22.2% |
Q2 2017 | $30,667,000 | +17.0% | 1,624,268 | +5.8% | 0.01% | +12.5% |
Q1 2017 | $26,201,000 | +13.4% | 1,535,804 | +1.7% | 0.01% | +14.3% |
Q4 2016 | $23,098,000 | -17.6% | 1,510,621 | -14.4% | 0.01% | -22.2% |
Q3 2016 | $28,035,000 | +21.2% | 1,765,420 | -0.2% | 0.01% | +12.5% |
Q2 2016 | $23,122,000 | +22.6% | 1,768,413 | +1.7% | 0.01% | +33.3% |
Q1 2016 | $18,864,000 | -4.8% | 1,739,598 | +1.8% | 0.01% | -14.3% |
Q4 2015 | $19,808,000 | +13.7% | 1,709,052 | +2.2% | 0.01% | +16.7% |
Q3 2015 | $17,417,000 | +12.8% | 1,671,538 | +30.5% | 0.01% | +20.0% |
Q2 2015 | $15,444,000 | -40.5% | 1,280,587 | -21.1% | 0.01% | -37.5% |
Q1 2015 | $25,959,000 | +6.1% | 1,622,430 | +1.6% | 0.01% | +14.3% |
Q4 2014 | $24,469,000 | +13.6% | 1,597,172 | -3.9% | 0.01% | 0.0% |
Q3 2014 | $21,535,000 | +8.0% | 1,662,370 | +27.8% | 0.01% | +16.7% |
Q2 2014 | $19,938,000 | -6.4% | 1,300,625 | -24.8% | 0.01% | -14.3% |
Q1 2014 | $21,299,000 | +36.8% | 1,728,862 | +29.0% | 0.01% | +40.0% |
Q4 2013 | $15,565,000 | -0.6% | 1,340,678 | +1.4% | 0.01% | -16.7% |
Q3 2013 | $15,654,000 | +27.6% | 1,322,175 | +7.0% | 0.01% | +50.0% |
Q2 2013 | $12,272,000 | – | 1,235,998 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |